Tilray Brands (NASDAQ:TLRY) Trading Down 9.6% – Should You Sell?

Shares of Tilray Brands, Inc. (NASDAQ:TLRY) fell 9.6% on Friday . The stock traded as low as $11.00 and last traded at $11.16. 22,342,539 shares traded hands during trading, an increase of 263% from the average session volume of 6,151,285 shares. The stock had previously closed at $12.34.

Tilray Brands News Summary

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Federal rescheduling could materially ease regulatory, research, tax and banking constraints for cannabis companies — a catalyst that lifted sector sentiment. Trump Orders Marijuana Reclassification: What It Means for the Sector
• Positive Sentiment: Tilray announced the launch of Tilray Medical USA to accelerate U.S. medical expansion — a direct strategic move to capture potential new market access if federal rescheduling reduces barriers. Tilray Accelerates U-S-Medical-Cannabis-Expansion…
• Neutral Sentiment: Coverage is clarifying that the executive order starts a process (DEA / DOJ rules, FDA guidance and congressional action may follow); benefits are meaningful but will unfold over months-to-years, not instantly. Trump moves to ease cannabis restrictions – what does it mean for consumers?
• Neutral Sentiment: Analysts and commentators warn rescheduling aids research and access to CBD products but is not an immediate demand multiplier — investors must wait for regulatory details and commercialization paths. Trump signs executive order easing federal restrictions on marijuana
• Negative Sentiment: After big gains earlier in the week, the stock has seen profit‑taking and mean‑reversion; some traders are locking gains, causing sharp intraday reversals. Coverage of the earlier rally and subsequent pullbacks highlights high volatility. Tilray Brands (TLRY) Stock Soars 27% on Cannabis Reclassification Talk
• Negative Sentiment: Bearish pieces and investor notes question near‑term profitability, valuation and whether rescheduling translates to material revenue growth for Tilray — adding selling pressure for risk‑off investors. Tilray Brands, Inc. (TLRY): A Bear Case Theory

Wall Street Analyst Weigh In

Several equities analysts have recently commented on TLRY shares. Jefferies Financial Group upped their price objective on shares of Tilray Brands from $15.00 to $20.00 and gave the stock a “buy” rating in a report on Monday, August 25th. Atb Cap Markets raised Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Wednesday, December 10th. Weiss Ratings restated a “sell (d-)” rating on shares of Tilray Brands in a research note on Wednesday, October 8th. Finally, Wall Street Zen upgraded Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Saturday, October 11th. Two research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $20.00.

Tilray Brands Stock Performance

The company has a current ratio of 2.62, a quick ratio of 1.56 and a debt-to-equity ratio of 0.15. The company has a market capitalization of $1.25 billion, a price-to-earnings ratio of -0.49 and a beta of 1.76. The stock’s fifty day simple moving average is $11.84 and its 200-day simple moving average is $9.91.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Integrated Wealth Concepts LLC increased its holdings in Tilray Brands by 33.8% during the 3rd quarter. Integrated Wealth Concepts LLC now owns 36,977 shares of the company’s stock worth $64,000 after purchasing an additional 9,341 shares during the period. CreativeOne Wealth LLC grew its position in shares of Tilray Brands by 12.2% during the third quarter. CreativeOne Wealth LLC now owns 87,134 shares of the company’s stock worth $151,000 after buying an additional 9,452 shares in the last quarter. Dudley Capital Management LLC increased its stake in shares of Tilray Brands by 73.3% during the third quarter. Dudley Capital Management LLC now owns 26,000 shares of the company’s stock worth $45,000 after buying an additional 11,000 shares during the period. Arizona State Retirement System raised its holdings in Tilray Brands by 4.3% in the third quarter. Arizona State Retirement System now owns 307,193 shares of the company’s stock valued at $531,000 after acquiring an additional 12,675 shares in the last quarter. Finally, Brighton Jones LLC lifted its stake in Tilray Brands by 28.3% in the third quarter. Brighton Jones LLC now owns 59,510 shares of the company’s stock worth $103,000 after acquiring an additional 13,137 shares during the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.